Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging quinoline‐ and quinolone‐based antibiotics in the light of epidemics
Paranjeet Kaur, A Anuradha, Avik Chandra, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 6, pp. 765-785
Closed Access | Times Cited: 24

Showing 24 citing articles:

Navigating Antibacterial Frontiers: A Panoramic Exploration of Antibacterial Landscapes, Resistance Mechanisms, and Emerging Therapeutic Strategies
Krittika Ralhan, Kavita A. Iyer, Leilani Lotti Díaz, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1483-1519
Open Access | Times Cited: 8
Optimal adsorption of pefloxacin antibiotics from aqueous solutions: Improved performance with metal-organic framework MIL-101(Cr)
Tien Tran Nguyen, Minh Kim Nguyen, Vipin Kumar, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 689, pp. 133642-133642
Closed Access | Times Cited: 5
Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens
Jingyue Gao, Haodong Hou, Feng Gao
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115026-115026
Closed Access | Times Cited: 24
New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus
Mohamed Samir, Mohamed Ramadan, Mostafa Abdelrahman, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117004-117004
Closed Access | Times Cited: 15
Synthesis, structural characterization and antibacterial activity evaluation of novel quinolone-1,2,3-triazole-benzimidazole hybrids
Khadija El Gadali, Meriem Rafya, Az‐Eddine El Mansouri, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135179-135179
Open Access | Times Cited: 9
Dual Antibiotic Approach: Synthesis and Antibacterial Activity of Antibiotic‐Antimicrobial Peptide Conjugates
Maria Cristina Bellucci, Carola Romani, Monica Sani, et al.
(2024)
Open Access | Times Cited: 2
Dual Antibiotic Approach: Synthesis and Antibacterial Activity of Antibiotic–Antimicrobial Peptide Conjugates
Maria Cristina Bellucci, Carola Romani, Monica Sani, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 783-783
Open Access | Times Cited: 2
Recent Developments to Cope the Antibacterial Resistance via β-Lactamase Inhibition
Zafar Iqbal, Jian Sun, Haikang Yang, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3832-3832
Open Access | Times Cited: 10
Microwave assisted synthesis of new quinolone and coumarin molecular hybrids: SAR, molecular modelling studies as dual antagonists and its antimicrobial evaluation targeting bacterial and fungal infections
Tella Lakshmi Viveka, Gangadhara Angajala, Valmiki Aruna, et al.
Journal of Molecular Structure (2024) Vol. 1303, pp. 137482-137482
Closed Access | Times Cited: 1
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2
Pranav Kumar Prabhakar, Gaber El-Saber Batiha
Current Medicinal Chemistry (2023) Vol. 31, Iss. 21, pp. 3167-3181
Closed Access | Times Cited: 3
Why are heterocycles so special in medicinal chemistry?
Bin Yu, Xiuyan Yang
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 6, pp. 763-764
Closed Access | Times Cited: 6
Safety and Efficacy of Nemonoxacin vs Levofloxacin in Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Control Trials
Alina Sami Khan, Arham Iqbal, Alina Amin Muhammad, et al.
Cureus (2023)
Open Access | Times Cited: 2
Synthetic Approaches for Annulated Quinolines at Face a
Youssef A. Alnamer, Magdy A. Ibrahim, Aya Ahmed, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 4, pp. 2863-2886
Closed Access | Times Cited: 2
Nucleoside hydrolase immobilized on magnetic particles as a tool for onflow screening and characterization of inhibitors
Pamella Christina Ortega de Oliveira, Millena Santana Ceroullo, Mayane Barbosa dos Santos, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 235, pp. 115589-115589
Closed Access | Times Cited: 2
N-Arylation of 3-Formylquinolin-2(1H)-ones Using Copper(II)-Catalyzed Chan–Lam Coupling
Jhesua Valencia, Oriel A. Sánchez-Velasco, Jorge Saavedra‐Olavarría, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8345-8345
Open Access | Times Cited: 4
Intramolecular Heterocyclization of Quinolyl-Substituted Carbothioamides to Functionalized 2,4-Dihydro-3H-1,2,4-triazoles and -1,3,4-thiadiazoles
Iskuhi L. Aleksanyan, L. P. Hambardzumyan
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 6, pp. 1022-1027
Closed Access
Design, Synthesis, and Evaluation of Quinoline‐1,2,3‐Triazole Hybrids as CYP51 Inhibitors: In Silico Study and In Vitro Antimicrobial Assessment
Bhadreshkumar K. Chabhadiya, Hem N. Naik, Bhavika A. Mohite, et al.
ChemistrySelect (2024) Vol. 9, Iss. 36
Closed Access
Coumarin-imidazopyridine hybrids and their first-in-class ZnII metal complexes as potent dual entry and replication inhibitors of Zika viral infection
Henrique Jefferson de Arruda, Larissa A. Ferreira, Gleyton Leonel Silva Sousa, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107889-107889
Closed Access
A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor Pathway
Panagiotis Ntavaroukas, Karim Michail, Rafaela Tsiakalidou, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 910-910
Open Access
Advances in the Synthesis and Biological Applications of Enoxacin-Based Compounds
Garba Suleiman, Nabil El Brahmi, Gérald Guillaumet, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1419-1419
Open Access
Antibacterial Activity of Squaric Amide Derivative SA2 against Methicillin-Resistant Staphylococcus aureus
Moxi Yu, Yachen Hou, Mei‐Ling Cheng, et al.
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1497-1497
Open Access | Times Cited: 2
Magic bullets, magic shields, and antimicrobials in between
Praveen Prathapan
Pharmaceutical Science Advances (2022) Vol. 1, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 2
Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging
Yuhao Jiang, Si’an Fang, Junhong Feng, et al.
Molecular Pharmaceutics (2022) Vol. 20, Iss. 1, pp. 630-640
Closed Access | Times Cited: 1
Emerging bioactive antiviral drugs in the light of epidemics
Deepali Gupta, Manish Chaudhary, Paranjeet Kaur, et al.
AIP conference proceedings (2023) Vol. 2804, pp. 020283-020283
Closed Access
Page 1

Scroll to top